Yuanbo Wu

1.4k total citations · 1 hit paper
49 papers, 1.1k citations indexed

About

Yuanbo Wu is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Yuanbo Wu has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Surgery. Recurrent topics in Yuanbo Wu's work include Speech and Audio Processing (6 papers), Speech Recognition and Synthesis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuanbo Wu is often cited by papers focused on Speech and Audio Processing (6 papers), Speech Recognition and Synthesis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuanbo Wu collaborates with scholars based in China, United States and Hong Kong. Yuanbo Wu's co-authors include Jian Zhou, Xiang Zhu, Guangwei Yang, Wenhua Xu, Hongqi Li, Zhi Tao, M.A. Daeschel, Weidong Wang, Wenting Li and Gengyun Sun and has published in prestigious journals such as Chemical Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuanbo Wu

48 papers receiving 1.1k citations

Hit Papers

Mitochondrial dysfunction in neurodegenerative diseases a... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Yuanbo Wu
Yubo Xie China
Qi Huang China
Xinhui Li China
Taewan Kim South Korea
S. R. Gullans United States
Amit Berson United States
Yubo Xie China
Yuanbo Wu
Citations per year, relative to Yuanbo Wu Yuanbo Wu (= 1×) peers Yubo Xie

Countries citing papers authored by Yuanbo Wu

Since Specialization
Citations

This map shows the geographic impact of Yuanbo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanbo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanbo Wu more than expected).

Fields of papers citing papers by Yuanbo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanbo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanbo Wu. The network helps show where Yuanbo Wu may publish in the future.

Co-authorship network of co-authors of Yuanbo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanbo Wu. A scholar is included among the top collaborators of Yuanbo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanbo Wu. Yuanbo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jie, Yuanbo Wu, Meng Mao, et al.. (2024). Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-κB Signaling Pathway in Mice. Drug Design Development and Therapy. Volume 18. 4449–4458. 2 indexed citations
2.
Zhang, Hongquan, Lili Wu, Jiang Li, et al.. (2024). Exosomes derived from endothelial progenitor cells ameliorate LPS-induced brain microvascular endothelial cells injury by delivering miR-126a-5p. Scientific Reports. 14(1). 18469–18469. 1 indexed citations
4.
Guo, Fei, Hongjun Zhu, Hao Su, et al.. (2022). Electro-characteristics of Myocardial Pouches and Reduction of the Frequency of Steam Pops During Radiofrequency Ablation. Frontiers in Physiology. 13. 816865–816865. 2 indexed citations
5.
Wu, Yuanbo, et al.. (2021). Polysaccharide-Based Lotus Seedpod Surface-Like Porous Microsphere as an Efficient Drug Carrier for Cancer Treatment. Cancer Management and Research. Volume 13. 4067–4076. 2 indexed citations
6.
Tang, Chaoliang, Yida Hu, Haiyan Lyu, et al.. (2020). Neuroprotective effects of 1‐O‐hexyl‐2,3,5‐trimethylhydroquinone on ischaemia/reperfusion‐induced neuronal injury by activating the Nrf2/HO‐1 pathway. Journal of Cellular and Molecular Medicine. 24(18). 10468–10477. 12 indexed citations
7.
Hu, Yida, Chaoliang Tang, Jiazhen Jiang, et al.. (2020). Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca2+-STIM1/Orai1 Signaling. Current Medical Science. 40(4). 699–707. 8 indexed citations
8.
Zhang, Xiang, Dezhi Cheng, Yu Liu, Yuanbo Wu, & Zhifeng He. (2019). <p>Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation</p>. Cancer Management and Research. Volume 11. 5333–5341. 4 indexed citations
9.
Wu, Yuanbo, et al.. (2019). Fistula from Congenital Subclavian Artery to Azygos Vein with Congestive Heart Failure in an Adult. Annals of Vascular Surgery. 58. 384.e1–384.e4.
10.
Wu, Yuanbo, et al.. (2019). Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 49. 35–45. 294 indexed citations breakdown →
11.
Wu, Yuanbo, et al.. (2017). MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress. Current Neurovascular Research. 14(2). 117–124. 30 indexed citations
12.
Yang, Guangwei, et al.. (2017). MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1. Biochemical and Biophysical Research Communications. 486(1). 29–35. 13 indexed citations
13.
Wu, Yuanbo, et al.. (2016). PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population. OncoTargets and Therapy. 9. 2919–2919. 1 indexed citations
15.
Li, Wenting, Chuanlong Zhu, Yuanbo Wu, Zheng Wang, & Chuanwu Zhu. (2015). Increased P ygo2 expression in liver of patients with hepatitis B virus‐related fibrosis. Liver International. 35(12). 2522–2529. 4 indexed citations
16.
Wu, Yuanbo, et al.. (2015). NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage. Biochemical and Biophysical Research Communications. 469(3). 392–398. 18 indexed citations
17.
Li, Wenting, et al.. (2014). Anti-fibrosis effects of Huisheng oral solution in CCl 4 -induced hepatic fibrosis in rat. Indian Journal of Pharmacology. 46(2). 216–216. 10 indexed citations
18.
Wu, Yuanbo, et al.. (2013). CHOP/ORP150 Ratio in Endoplasmic Reticulum Stress: A New Mechanism for Diabetic Peripheral Neuropathy. Cellular Physiology and Biochemistry. 32(2). 367–379. 34 indexed citations
19.
Xu, Wenhua, Aimei Zhang, Xu Dong Zhang, et al.. (2012). Changes of Treg-Associated Molecules on CD4+CD25+Treg Cells in Myasthenia Gravis and Effects of Immunosuppressants. Journal of Clinical Immunology. 32(5). 975–983. 42 indexed citations
20.
Mou, Xiaoning, Yuanbo Wu, Henghua Cao, et al.. (2012). Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome. Stem Cell Research & Therapy. 3(2). 14–14. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026